APA (7th ed.) Citation

Ohnaka, M., Sakurada, Y., Hayashi, A., Kadonosono, K., Ohno, H., Mori, R., . . . Takahashi, H. (2025). Real-World Outcomes of Brolucizumab Treatment in Japanese Patients with Neovascular Age-Related Macular Degeneration: A 12-Month, Multicenter Study. Ophthalmology & Therapy, 14(7), 1551. https://doi.org/10.1007/s40123-025-01159-2

Chicago Style (17th ed.) Citation

Ohnaka, Masayuki, et al. "Real-World Outcomes of Brolucizumab Treatment in Japanese Patients with Neovascular Age-Related Macular Degeneration: A 12-Month, Multicenter Study." Ophthalmology & Therapy 14, no. 7 (2025): 1551. https://doi.org/10.1007/s40123-025-01159-2.

MLA (9th ed.) Citation

Ohnaka, Masayuki, et al. "Real-World Outcomes of Brolucizumab Treatment in Japanese Patients with Neovascular Age-Related Macular Degeneration: A 12-Month, Multicenter Study." Ophthalmology & Therapy, vol. 14, no. 7, 2025, p. 1551, https://doi.org/10.1007/s40123-025-01159-2.